Cited by 72Bacterial Infections and VaccinesMicrobial infections and disease researchBacterial Identification and Susceptibility Testing

Meningococcal Carriage Following a Vaccination Campaign With MenB-4C and MenB-FHbp in Response to a University Serogroup B Meningococcal Disease Outbreak-Oregon, 2015–2016

Open access
McNamara, Lucy A, Thomas, Jennifer Dolan, MacNeil, Jessica, Chang, How Yi, Day, Michael, Fisher, Emily, Martin, Stacey, Poissant, Tasha +63 more·2017·The Journal of Infectious Diseases

Abstract

Background: Limited data exist on the impact of the serogroup B meningococcal (MenB) vaccines MenB-FHbp and MenB-4C on meningococcal carriage and herd protection. We therefore assessed meningococcal carriage following a MenB vaccination campaign in response to a university serogroup B meningococcal disease outbreak in 2015. Methods: A convenience sample of students recommended for vaccination provided oropharyngeal swab specimens and completed questionnaires during 4 carriage surveys over 11 months. Isolates were tested by real-time polymerase chain reaction analysis, slide agglutination, and whole-genome sequencing. Vaccination history was verified via university records and the state immunization registry. Results: A total of 4225 oropharyngeal swab specimens from 3802 unique participants were analyzed. Total meningococcal and genotypically serogroup B carriage prevalence among sampled students were stable, at 11%-17% and 1.2%-2.4% during each round, respectively; no participants carried the outbreak strain. Neither 1-3 doses of MenB-FHbp nor 1-2 doses of MenB-4C was associated with decreased total or serogroup B carriage prevalence. Conclusions: While few participants completed the full MenB vaccination series, limiting analytic power, these data suggest that MenB-FHbp and MenB-4C do not have a large, rapid impact on meningococcal carriage and are unlikely to provide herd protection in the context of an outbreak response.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/jix446

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A N. meningitidis serogroup B protein-based vaccine has been developed and use has been shown to limit outbreaks.

    “More recently a N. meningitidis serogroup B protein-based vaccine has been developed and use has been shown to limit outbreaks. [81, 82]”

    From Global etiology of bacterial meningitis: A systematic review and meta-analysis. (2018) · cites this paper as [82]

    The Introduction (page not specified) identifies two licensed protein-based MenB vaccines used in response to a university outbreak. But the Discussion (page not specified) does not show that their use limited outbreaks: it reports no large, rapid effect on carriage and says rapid herd protection is unlikely, while noting their role in individual protection. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
McNamara, L. A., Thomas, J. D., MacNeil, J., Chang, H. Y., Day, M., Fisher, E., Martin, S., Poissant, T., Schmink, S. E., Steward-Clark, E., Jenkins, L. T., Wang, X., Acosta, A., Oregon Meningococcal Carriage Team, Angelo, K., Blain, A., Cassiday, P., Changayil, S., Church, E. C., Diebold, K., Ewumi, S., Faulkner, A., Fisun, H., Haberman, H., Harcourt, B., Haring, S., Hughes, L., Joseph, S., Kumaran, N., Lee, A., Lennon, T., Link-Gelles, R., Lu, L. (., Marcinkevage, J., Mayer, L., Milucky, J., Miner, C., Nelson, J., Patel, M., Paulos, S., Pinell-McNamara, V., Quinn, C., Rajam, G., Redman, R., Retchless, A., Rosenthal, M., Semenova, V., Skoff, T., Smulian, E., Stanley, T., Stratton, E., Talley, P., Tiwari, T., Toews, K.-A., Westercamp, M., Cieslak, P., DeSilva, M., Alviani, N., Biel, F., Burkhalter, B., Francis, M., Howe, P., Jackson, E., Johnson, T., Luedtke, P., Manning, Z., Muno, E., Roberts, T., Roberts, Z., Eyster, M., & Hollands, C.
Affiliations
  • National Center for Immunization and Respiratory Diseases (US)
  • Oregon Health Authority (US)
  • Centers for Disease Control and Prevention (US)
  • Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases
Corresponding author
McNamara, Lucy A
Venue
The Journal of Infectious Diseases
Published
2017-08-26
Volume
216
Issue
9
Pages
1130-1140
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2788205471
Cited by
72
References
24
Citations by year
2026: 4 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 8 · 2021: 9 · 2020: 15 · 2019: 10 · 2018: 16
FWCI
9.06
Type
journal article
Language
en
Open access
Locations
  • The Journal of Infectious Diseases (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
Centers for Disease Control and Prevention
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Bacterial Identification and Susceptibility Testing
Keywords
meningococcal serogroup B, Neisseria meningitidis, meningococcal carriage, vaccination campaigns, herd protection, carriage prevalence, vaccine impact, whole genome sequencing, outbreak response
MeSH terms
Antigens, Bacterial, Disease Outbreaks, Female, Humans, Male, Meningococcal Infections, Oregon, Universities, Vaccination, Immunization Programs, Meningococcal Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review